Viewing Study NCT05092451

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:57 PM
Ignite Modification Date: 2026-02-21 @ 9:24 PM
Study NCT ID: NCT05092451
Status: RECRUITING
Last Update Posted: 2025-08-13
First Post: 2021-10-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None B-Cell Lymphoma View
None Myelodysplastic Syndromes (MDS) View
None Acute Myeloid Leukemia (AML) View
None Multiple Myeloma View
None Plasma Cell Leukemia View
None Hodgkin Lymphoma View
None T-cell Non-Hodgkin's Lymphoma/ T-cell Acute Lymphoblastic Leukmeia View
None Myelodysplastic Syndrome / Chronic Myelomonocytic Leukemia View
None Blastic Transformation of Chronic Myeloid Leukemia View
None Germ Cell Tumors View
Keywords: